ATRA vs DVA · rev $128.9M vs P/E 14, rev $12.82B
Atara Biotherapeutics Inc (ATRA) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
ATRA currently screens at market cap $87.1M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the ATRA and DVA stock pages for the full models.
Not investment advice.